Related Experiment Video
Updated: Jan 30, 2026

The Use of Thermal Infra-Red Imaging to Detect Delayed Onset Muscle Soreness
Published on: January 22, 2012
Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model
Osnat Ashur-Fabian1,2, Ofira Zloto3, Ina Fabian4
1Department of Human Molecular Genetics and Biochemistry, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract:
Ocular melanoma research, the most common primary intraocular malignancy in adults, is hindered by limited in vivo models. In a series of experiments using melanoma cells injected intraocularly into mouse eyes, we developed a model for ocular melanoma. Inoculation of 5 × 105 B16F10 cells led to rapid tumor growth, extensive lung metastasis, and limited animal survival, while injection of 102 cells was sufficient for intraocular tumors to grow with extended survival. In order to improve tumor visualization, 102 melanoma cells (B16F10 or B16LS9) were inoculated into Balb/C albino mouse eyes. These mice developed intraocular tumors that did not metastasize and exhibited extended survival. Next, we studied the therapeutic potential of inhibitor of the thyroid hormones-αvβ3 integrin signaling pathway in ocular melanoma. By utilizing tetraiodothyroacetic acid (tetrac), a thyroid hormone derivative, a delay in tumor onset in the B16F10 (integrin+) arm was observed, compared to the untreated group, while in the B16LS9 cells (integrin-) a similar rate of tumor onset was noticed in both experimental and control groups. In summary, following an optimization process, the mouse ocular melanoma model was developed. The models exhibited an extended therapeutic window and can be utilized as a platform for investigating various drugs and other treatment modalities.
Insights
Researchers developed a new mouse model for ocular melanoma, the most common adult eye cancer. This model aids in testing new treatments for intraocular tumors, improving drug discovery for this rare cancer.
Area of Science:
- Ophthalmology
- Oncology
- Translational Medicine
Background:
- Ocular melanoma, the most common primary intraocular malignancy in adults, lacks adequate in vivo models for research.
- Limited availability of effective in vivo models hinders the study of ocular melanoma progression and treatment.
Purpose of the Study:
- To develop and optimize a reproducible mouse model for ocular melanoma.
- To establish a platform for evaluating therapeutic interventions in ocular melanoma.
Main Methods:
- Intraocular inoculation of B16F10 or B16LS9 melanoma cells into Balb/C albino mice.
- Optimization of cell dosage (10^2 cells) for tumor growth with extended survival and reduced metastasis.
- Administration of tetraiodothyroacetic acid (tetrac) to investigate therapeutic potential targeting the αvβ3 integrin pathway.
Main Results:
- Optimized mouse model successfully developed intraocular tumors with extended survival and no metastasis.
- Tetraiodothyroacetic acid (tetrac) demonstrated a delay in tumor onset in integrin-positive (B16F10) cells, but not in integrin-negative (B16LS9) cells.
- The developed model provides an extended therapeutic window for drug evaluation.
Conclusions:
- The optimized mouse ocular melanoma model is a valuable platform for preclinical research.
- The model facilitates the investigation of therapeutic strategies targeting specific molecular pathways in ocular melanoma.
- This research advances the development of new treatments for ocular melanoma.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Molecular Models
The Bohr Model
Stereotype Content Model
Compartment Models: Two-Compartment Model
Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...

